Vascular endothelial growth factor and angiogenesis

ANN Hoeben, B Landuyt, MS Highley, H Wildiers… - Pharmacological …, 2004 - ASPET
Angiogenesis is a hallmark of wound healing, the menstrual cycle, cancer, and various
ischemic and inflammatory diseases. A rich variety of pro-and antiangiogenic molecules …

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

HF Dvorak - Journal of clinical oncology, 2002 - ascopubs.org
Vascular endothelial growth factor A (VEGF-A), the founding member of the vascular
permeability factor (VPF)/VEGF family of proteins, is an important angiogenic cytokine with …

VEGF receptor signal transduction

T Matsumoto, L Claesson-Welsh - Science's STKE, 2001 - science.org
The family of vascular endothelial growth factors (VEGFs) currently includes VEGF-A,-B,-C,-
D,-E, and placenta growth factor (PlGF). Several of these factors, notably VEGF-A, exist as …

Proteomics: new perspectives, new biomedical opportunities

RE Banks, MJ Dunn, DF Hochstrasser, JC Sanchez… - The Lancet, 2000 - thelancet.com
Proeomics-based approaches, which examine the expressed proteins of a tissue or cell
type, complement the genome initiatives and are increasingly being used to address …

Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers

LS Rosen - Cancer control, 2002 - journals.sagepub.com
Angiogenesis is required for tumor growth and metastasis and, therefore, represents an
exciting target for cancer treatment. Angiogenesis is a complex process that is tightly …

Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth …

F Ciardiello, R Caputo, V Damiano, R Caputo… - Clinical Cancer …, 2003 - AACR
Purpose: Vascular endothelial growth factor (VEGF) is a major mitogen for endothelial cells
and enhances vascular permeability. Enhanced VEGF secretion is found in human cancers …

Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol

L Labrecque, I Royal, DS Surprenant… - Molecular biology of …, 2003 - Am Soc Cell Biol
The stimulation of vascular endothelial growth factor receptor-2 (VEGFR-2) by tumor-derived
VEGF represents a key event in the initiation of angiogenesis. In this work, we report that …

Transcriptional response to hypoxia in human tumors

A Lal, H Peters, B St. Croix, ZA Haroon… - Journal of the …, 2001 - academic.oup.com
Background: The presence of hypoxic regions within solid tumors is associated with a more
malignant tumor phenotype and worse prognosis. To obtain a blood supply and protect …

Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 …

D Wei, L Wang, Y He, HQ Xiong, JL Abbruzzese, K Xie - Cancer research, 2004 - AACR
The aggressive biology of human pancreatic adenocarcinoma has been linked with
overexpression of vascular endothelial growth factor (VEGF). Constitutive activation of the …

Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation

S Lamy, D Gingras, R Béliveau - Cancer research, 2002 - AACR
Vascular endothelial growth factor (VEGF) receptors (VEGFR) play a major role in tumor
angiogenesis and, thus, represent attractive targets for the development of novel anticancer …